ETR:COP

CompuGroup Medical SE & Co. KGaA Competitors

€74.25
+0.85 (+1.16 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
€73.20
Now: €74.25
€74.80
50-Day Range
€65.70
MA: €70.63
€74.00
52-Week Range
€62.70
Now: €74.25
€85.40
Volume123,184 shs
Average Volume68,245 shs
Market Capitalization$3.99 billion
P/E Ratio53.04
Dividend Yield0.69%
BetaN/A

Competitors

CompuGroup Medical SE & Co. KGaA (ETR:COP) Vs. BC8, NEM, G24, VAR1, OSR, and DLG

Should you be buying COP stock or one of its competitors? Companies in the sector of "computer and technology" are considered alternatives and competitors to CompuGroup Medical SE & Co. KGaA, including Bechtle (BC8), Nemetschek (NEM), Scout24 (G24), Varta (VAR1), OSRAM Licht (OSR), and Dialog Semiconductor (DLG).

Bechtle (ETR:BC8) and CompuGroup Medical SE & Co. KGaA (ETR:COP) are both mid-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability and earnings.

Dividends

Bechtle pays an annual dividend of €1.35 per share and has a dividend yield of 0.8%. CompuGroup Medical SE & Co. KGaA pays an annual dividend of €0.50 per share and has a dividend yield of 0.7%. Bechtle pays out 29.5% of its earnings in the form of a dividend. CompuGroup Medical SE & Co. KGaA pays out 35.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bechtle is clearly the better dividend stock, given its higher yield and lower payout ratio.

Analyst Ratings

This is a summary of current ratings and price targets for Bechtle and CompuGroup Medical SE & Co. KGaA, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bechtle14402.33
CompuGroup Medical SE & Co. KGaA11202.25

Bechtle presently has a consensus price target of €164.50, indicating a potential downside of 3.18%. CompuGroup Medical SE & Co. KGaA has a consensus price target of €82.75, indicating a potential upside of 11.45%. Given CompuGroup Medical SE & Co. KGaA's higher probable upside, analysts clearly believe CompuGroup Medical SE & Co. KGaA is more favorable than Bechtle.

Earnings and Valuation

This table compares Bechtle and CompuGroup Medical SE & Co. KGaA's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bechtle$5.82 billion1.23$192.53 million€4.5837.06
CompuGroup Medical SE & Co. KGaA$869.21 million4.59$75.23 million€1.4053.04

Bechtle has higher revenue and earnings than CompuGroup Medical SE & Co. KGaA. Bechtle is trading at a lower price-to-earnings ratio than CompuGroup Medical SE & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Bechtle and CompuGroup Medical SE & Co. KGaA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BechtleN/AN/AN/A
CompuGroup Medical SE & Co. KGaAN/AN/AN/A

Summary

Bechtle beats CompuGroup Medical SE & Co. KGaA on 7 of the 10 factors compared between the two stocks.

Nemetschek (ETR:NEM) and CompuGroup Medical SE & Co. KGaA (ETR:COP) are both mid-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends and earnings.

Dividends

Nemetschek pays an annual dividend of €0.30 per share and has a dividend yield of 0.5%. CompuGroup Medical SE & Co. KGaA pays an annual dividend of €0.50 per share and has a dividend yield of 0.7%. Nemetschek pays out 35.8% of its earnings in the form of a dividend. CompuGroup Medical SE & Co. KGaA pays out 35.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CompuGroup Medical SE & Co. KGaA is clearly the better dividend stock, given its higher yield and lower payout ratio.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Nemetschek and CompuGroup Medical SE & Co. KGaA, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nemetschek23502.30
CompuGroup Medical SE & Co. KGaA11202.25

Nemetschek presently has a consensus price target of €62.45, indicating a potential upside of 4.29%. CompuGroup Medical SE & Co. KGaA has a consensus price target of €82.75, indicating a potential upside of 11.45%. Given CompuGroup Medical SE & Co. KGaA's higher probable upside, analysts plainly believe CompuGroup Medical SE & Co. KGaA is more favorable than Nemetschek.

Valuation & Earnings

This table compares Nemetschek and CompuGroup Medical SE & Co. KGaA's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nemetschek$596.91 million11.59$96.90 million€0.8471.37
CompuGroup Medical SE & Co. KGaA$869.21 million4.59$75.23 million€1.4053.04

Nemetschek has higher earnings, but lower revenue than CompuGroup Medical SE & Co. KGaA. CompuGroup Medical SE & Co. KGaA is trading at a lower price-to-earnings ratio than Nemetschek, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Nemetschek and CompuGroup Medical SE & Co. KGaA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NemetschekN/AN/AN/A
CompuGroup Medical SE & Co. KGaAN/AN/AN/A

Scout24 (ETR:G24) and CompuGroup Medical SE & Co. KGaA (ETR:COP) are both mid-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends and earnings.

Dividends

Scout24 pays an annual dividend of €1.82 per share and has a dividend yield of 2.6%. CompuGroup Medical SE & Co. KGaA pays an annual dividend of €0.50 per share and has a dividend yield of 0.7%. Scout24 pays out 7.9% of its earnings in the form of a dividend. CompuGroup Medical SE & Co. KGaA pays out 35.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Scout24 is clearly the better dividend stock, given its higher yield and lower payout ratio.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Scout24 and CompuGroup Medical SE & Co. KGaA, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Scout2404602.60
CompuGroup Medical SE & Co. KGaA11202.25

Scout24 presently has a consensus price target of €70.59, indicating a potential upside of 2.16%. CompuGroup Medical SE & Co. KGaA has a consensus price target of €82.75, indicating a potential upside of 11.45%. Given CompuGroup Medical SE & Co. KGaA's higher probable upside, analysts plainly believe CompuGroup Medical SE & Co. KGaA is more favorable than Scout24.

Valuation & Earnings

This table compares Scout24 and CompuGroup Medical SE & Co. KGaA's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scout24$375.77 million17.99$2.27 billion€23.172.98
CompuGroup Medical SE & Co. KGaA$869.21 million4.59$75.23 million€1.4053.04

Scout24 has higher earnings, but lower revenue than CompuGroup Medical SE & Co. KGaA. Scout24 is trading at a lower price-to-earnings ratio than CompuGroup Medical SE & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Scout24 and CompuGroup Medical SE & Co. KGaA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Scout24N/AN/AN/A
CompuGroup Medical SE & Co. KGaAN/AN/AN/A

Summary

Scout24 beats CompuGroup Medical SE & Co. KGaA on 7 of the 10 factors compared between the two stocks.

Varta (ETR:VAR1) and CompuGroup Medical SE & Co. KGaA (ETR:COP) are both mid-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends and earnings.

Dividends

Varta pays an annual dividend of €2.50 per share and has a dividend yield of 2.0%. CompuGroup Medical SE & Co. KGaA pays an annual dividend of €0.50 per share and has a dividend yield of 0.7%. Varta pays out 105.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. CompuGroup Medical SE & Co. KGaA pays out 35.7% of its earnings in the form of a dividend.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Varta and CompuGroup Medical SE & Co. KGaA, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Varta53001.38
CompuGroup Medical SE & Co. KGaA11202.25

Varta presently has a consensus price target of €102.57, indicating a potential downside of 18.59%. CompuGroup Medical SE & Co. KGaA has a consensus price target of €82.75, indicating a potential upside of 11.45%. Given CompuGroup Medical SE & Co. KGaA's stronger consensus rating and higher probable upside, analysts plainly believe CompuGroup Medical SE & Co. KGaA is more favorable than Varta.

Valuation & Earnings

This table compares Varta and CompuGroup Medical SE & Co. KGaA's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Varta$874.56 million5.82$95.40 million€2.3653.39
CompuGroup Medical SE & Co. KGaA$869.21 million4.59$75.23 million€1.4053.04

Varta has higher revenue and earnings than CompuGroup Medical SE & Co. KGaA. CompuGroup Medical SE & Co. KGaA is trading at a lower price-to-earnings ratio than Varta, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Varta and CompuGroup Medical SE & Co. KGaA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
VartaN/AN/AN/A
CompuGroup Medical SE & Co. KGaAN/AN/AN/A

Summary

Varta beats CompuGroup Medical SE & Co. KGaA on 6 of the 10 factors compared between the two stocks.

OSRAM Licht (ETR:OSR) and CompuGroup Medical SE & Co. KGaA (ETR:COP) are both mid-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends and earnings.

Valuation & Earnings

This table compares OSRAM Licht and CompuGroup Medical SE & Co. KGaA's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OSRAM Licht$3.01 billion1.64$-176,876,981.09(€1.88)-27.90
CompuGroup Medical SE & Co. KGaA$869.21 million4.59$75.23 million€1.4053.04

CompuGroup Medical SE & Co. KGaA has lower revenue, but higher earnings than OSRAM Licht. OSRAM Licht is trading at a lower price-to-earnings ratio than CompuGroup Medical SE & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings and recommmendations for OSRAM Licht and CompuGroup Medical SE & Co. KGaA, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
OSRAM Licht0000N/A
CompuGroup Medical SE & Co. KGaA11202.25

CompuGroup Medical SE & Co. KGaA has a consensus price target of €82.75, indicating a potential upside of 11.45%. Given CompuGroup Medical SE & Co. KGaA's higher probable upside, analysts plainly believe CompuGroup Medical SE & Co. KGaA is more favorable than OSRAM Licht.

Dividends

OSRAM Licht pays an annual dividend of €1.11 per share and has a dividend yield of 2.1%. CompuGroup Medical SE & Co. KGaA pays an annual dividend of €0.50 per share and has a dividend yield of 0.7%. OSRAM Licht pays out -59.1% of its earnings in the form of a dividend. CompuGroup Medical SE & Co. KGaA pays out 35.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. OSRAM Licht is clearly the better dividend stock, given its higher yield and lower payout ratio.

Profitability

This table compares OSRAM Licht and CompuGroup Medical SE & Co. KGaA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
OSRAM LichtN/AN/AN/A
CompuGroup Medical SE & Co. KGaAN/AN/AN/A

Summary

CompuGroup Medical SE & Co. KGaA beats OSRAM Licht on 6 of the 9 factors compared between the two stocks.

CompuGroup Medical SE & Co. KGaA (ETR:COP) and Dialog Semiconductor (ETR:DLG) are both mid-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends.

Analyst Ratings

This is a breakdown of recent ratings for CompuGroup Medical SE & Co. KGaA and Dialog Semiconductor, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CompuGroup Medical SE & Co. KGaA11202.25
Dialog Semiconductor06502.45

CompuGroup Medical SE & Co. KGaA currently has a consensus price target of €82.75, suggesting a potential upside of 11.45%. Dialog Semiconductor has a consensus price target of €63.14, suggesting a potential downside of 2.33%. Given CompuGroup Medical SE & Co. KGaA's higher possible upside, equities research analysts plainly believe CompuGroup Medical SE & Co. KGaA is more favorable than Dialog Semiconductor.

Valuation and Earnings

This table compares CompuGroup Medical SE & Co. KGaA and Dialog Semiconductor's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CompuGroup Medical SE & Co. KGaA$869.21 million4.59$75.23 million€1.4053.04
Dialog Semiconductor$1.38 billion3.35$70.06 million€0.9865.76

CompuGroup Medical SE & Co. KGaA has higher earnings, but lower revenue than Dialog Semiconductor. CompuGroup Medical SE & Co. KGaA is trading at a lower price-to-earnings ratio than Dialog Semiconductor, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares CompuGroup Medical SE & Co. KGaA and Dialog Semiconductor's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CompuGroup Medical SE & Co. KGaAN/AN/AN/A
Dialog SemiconductorN/AN/AN/A


CompuGroup Medical SE & Co. KGaA Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Bechtle logo
BC8
Bechtle
1.2$169.90+0.9%$7.14 billion$5.82 billion37.06Analyst Report
Nemetschek logo
NEM
Nemetschek
1.1$59.88+1.5%$6.92 billion$596.91 million71.37Analyst Report
High Trading Volume
Scout24 logo
G24
Scout24
1.5$69.10+1.1%$6.76 billion$375.77 million2.98
Varta logo
VAR1
Varta
1.1$126.00+3.7%$5.09 billion$874.56 million53.39High Trading Volume
News Coverage
OSR
OSRAM Licht
0.7$52.40+0.2%$4.94 billion$3.01 billion-27.90High Trading Volume
Dialog Semiconductor logo
DLG
Dialog Semiconductor
1.1$64.64+0.1%$4.61 billion$1.38 billion65.76Analyst Report
News Coverage
RKET
Rocket Internet
0.7$24.02+0.8%$3.26 billion$81 million-12.77High Trading Volume
Software Aktiengesellschaft logo
SOW
Software Aktiengesellschaft
1.2$36.72+0.3%$2.72 billion$834.85 million28.47News Coverage
Aixtron logo
AIXA
Aixtron
1.3$19.28+1.3%$2.16 billion$269.25 million62.19Analyst Report
Xing logo
O1BC
Xing
0.8$346.00+0.0%$1.94 billion$240.79 million57.67
Cancom logo
COK
Cancom
1.6$49.54+0.3%$1.91 billion$1.66 billion30.96
SMA Solar Technology logo
S92
SMA Solar Technology
1.1$49.48+0.1%$1.72 billion$1.03 billion61.09
S&T logo
SANT
S&T
1.6$23.42+1.5%$1.51 billion$1.27 billion27.88
Jenoptik logo
JEN
Jenoptik
1.4$25.46+1.0%$1.46 billion$767.20 million34.88Analyst Report
RIB Software logo
RIB
RIB Software
1.0$27.35+5.7%$1.42 billion$254.58 million84.41Gap Up
Isra Vision logo
ISR
Isra Vision
0.6$47.45+0.1%$1.04 billion$122.19 million149.21High Trading Volume
ADVA Optical Networking logo
ADV
ADVA Optical Networking
0.9$9.86+1.6%$497.90 million$564.96 million24.65Upcoming Earnings
M5Z
Manz
0.5$56.80+6.0%$439.86 million$242.56 million135.24High Trading Volume
News Coverage
GFT Technologies logo
GFT
GFT Technologies
1.1$16.44+0.6%$432.87 million$444.85 million43.49
HNL
Dr. Hönle
1.5$47.30+0.6%$286.73 million$95.09 million56.11High Trading Volume
HOC
HolidayCheck Group
0.7$2.25+0.0%$196.81 million$17.86 million-1.79High Trading Volume
Wirecard logo
WDI
Wirecard
1.9$0.40+0.0%$49.24 million$2.58 billion0.10
SYV
3D Systems
0.6$9.22+0.0%$0.00N/A0.00High Trading Volume
OU1
Absolute Software
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
Capgemini logo
CAP
Capgemini
0.7$151.30+0.2%$0.00N/A0.00
Infineon Technologies logo
IFXA
Infineon Technologies
0.6N/AN/A$0.00N/A0.00Analyst Report
OSRAM Licht logo
OSR
OSRAM Licht
0.6$52.40+0.2%$0.00N/A0.00High Trading Volume
News Coverage
Proximus logo
PROX
Proximus
0.4N/AN/A$0.00N/A0.00Gap Down
Prysmian logo
PRY
Prysmian
0.7N/AN/A$0.00N/A0.00News Coverage
Gap Down
REY
Reply
0.5N/AN/A$0.00N/A0.00
Rocket Internet logo
RKET
Rocket Internet
0.8$24.02+0.8%$0.00N/A0.00High Trading Volume
Rogers logo
ROG
Rogers
0.7N/AN/A$0.00N/A0.00Gap Down
Siltronic logo
WAF
Siltronic
0.8$139.80+0.5%$0.00N/A0.00Analyst Report
High Trading Volume
STMicroelectronics logo
STM
STMicroelectronics
1.1$32.58+0.7%$0.00N/A0.00Analyst Report
Vivendi logo
VIV
Vivendi
1.3$28.55+0.1%$0.00N/A0.00
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.